These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11761459)

  • 1. Thymidine phosphorylase as a target for imaging and therapy with thymine analogs.
    Klecker RW; Collins JM
    Cancer Chemother Pharmacol; 2001 Nov; 48(5):407-12. PubMed ID: 11761459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5'-O-tritylated nucleoside derivatives: inhibition of thymidine phosphorylase and angiogenesis.
    Liekens S; Bronckaers A; Hernández AI; Priego EM; Casanova E; Camarasa MJ; Pérez-Pérez MJ; Balzarini J
    Mol Pharmacol; 2006 Aug; 70(2):501-9. PubMed ID: 16675660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and localization of thymidine phosphorylase/platelet-derived endothelial cell growth factor in skin and cutaneous tumors.
    Asgari MM; Haggerty JG; McNiff JM; Milstone LM; Schwartz PM
    J Cutan Pathol; 1999 Jul; 26(6):287-94. PubMed ID: 10472757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nucleoside derivative 5'-O-trityl-inosine (KIN59) suppresses thymidine phosphorylase-triggered angiogenesis via a noncompetitive mechanism of action.
    Liekens S; Hernández AI; Ribatti D; De Clercq E; Camarasa MJ; Pérez-Pérez MJ; Balzarini J
    J Biol Chem; 2004 Jul; 279(28):29598-605. PubMed ID: 15123637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic analysis of novel multisubstrate analogue inhibitors of thymidine phosphorylase.
    Balzarini J; Degrève B; Esteban-Gamboa A; Esnouf R; De Clercq E; Engelborghs Y; Camarasa MJ; Pérez-Pérez MJ
    FEBS Lett; 2000 Oct; 483(2-3):181-5. PubMed ID: 11042277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymidine phosphorylase is noncompetitively inhibited by 5'-O-trityl-inosine (KIN59) and related compounds.
    Liekens S; Balzarini J; Hernández AI; De Clercq E; Priego EM; Camarasa MJ; Pérez-Pérez MJ
    Nucleosides Nucleotides Nucleic Acids; 2006; 25(9-11):975-80. PubMed ID: 17065049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 7-Deazaxanthine, a novel prototype inhibitor of thymidine phosphorylase.
    Balzarini J; Gamboa AE; Esnouf R; Liekens S; Neyts J; De Clercq E; Camarasa MJ; Pérez-Pérez MJ
    FEBS Lett; 1998 Oct; 438(1-2):91-5. PubMed ID: 9821965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of thymidine phosphorylase in human superficial bladder cancer.
    Shimabukuro T; Matsuyama H; Baba Y; Jojima K; Suyama K; Aoki A; Suga A; Yamamoto N; Naito K
    Int J Urol; 2005 Jan; 12(1):29-34. PubMed ID: 15661051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of susceptibility of bicyclic nucleoside analogs, highly potent inhibitors of varicella-zoster virus, to the catabolic action of thymidine phosphorylase and dihydropyrimidine dehydrogenase.
    Balzarini J; Sienaert R; Liekens S; Van Kuilenburg A; Carangio A; Esnouf R; De Clercq E; McGuigan C
    Mol Pharmacol; 2002 May; 61(5):1140-5. PubMed ID: 11961132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of histidine-85 in the catalytic mechanism of thymidine phosphorylase as assessed by targeted molecular dynamics simulations and quantum mechanical calculations.
    Mendieta J; Martín-Santamaría S; Priego EM; Balzarini J; Camarasa MJ; Pérez-Pérez MJ; Gago F
    Biochemistry; 2004 Jan; 43(2):405-14. PubMed ID: 14717594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymidine phosphorylase inhibitors: recent developments and potential therapeutic applications.
    Pérez-Pérez MJ; Priego EM; Hernández AI; Camarasa MJ; Balzarini J; Liekens S
    Mini Rev Med Chem; 2005 Dec; 5(12):1113-23. PubMed ID: 16375757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5'-O-tritylinosine and analogues as allosteric inhibitors of human thymidine phosphorylase.
    Casanova E; Hernandez AI; Priego EM; Liekens S; Camarasa MJ; Balzarini J; Pérez-Pérez MJ
    J Med Chem; 2006 Sep; 49(18):5562-70. PubMed ID: 16942029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and activity of specific inhibitors of thymidine phosphorylase to potentiate the function of antitumor 2'-deoxyribonucleosides.
    Fukushima M; Suzuki N; Emura T; Yano S; Kazuno H; Tada Y; Yamada Y; Asao T
    Biochem Pharmacol; 2000 May; 59(10):1227-36. PubMed ID: 10736423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of thymidine phosphorylase in vivo provides a rapid method for switching DNA labeling.
    Womack JE
    Mol Gen Genet; 1977 Dec; 158(1):11-5. PubMed ID: 342905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and enzymatic evaluation of multisubstrate analogue inhibitors of Escherichia coli thymidine phosphorylase.
    Esteban-Gamboa A; Balzarini J; Esnouf R; De Clercq E; Camarasa MJ; Pérez-Pérez MJ
    J Med Chem; 2000 Mar; 43(5):971-83. PubMed ID: 10715161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-Ethoxy-2'-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expression.
    Schwartz EL; Baptiste N; Megati S; Wadler S; Otter BA
    Cancer Res; 1995 Aug; 55(16):3543-50. PubMed ID: 7627962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards new thymidine phosphorylase/PD-ECGF inhibitors based on the transition state of the enzyme reaction.
    Priego EM; Mendieta J; Gago F; Balzarini J; De Clercq E; Camarasa MJ; Pérez-Pérez MJ
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):951-3. PubMed ID: 14565319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in tumor behavior.
    Bijnsdorp IV; de Bruin M; Laan AC; Fukushima M; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):681-91. PubMed ID: 18600526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of the thymidine phosphorylase (platelet-derived endothelial cell growth factor) on tumor angiogenesis. Catalytic activity of enzyme inhibitors].
    Miszczak-Zaborska E; Smolarek M; Bartkowiak J
    Postepy Biochem; 2010; 56(1):61-6. PubMed ID: 20499682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidine phosphorylase activity and prodrug effects in a three-dimensional model of angiogenesis: implications for the treatment of ovarian cancer.
    Stevenson DP; Collins WP; Farzaneh F; Hata K; Miyazaki K
    Am J Pathol; 1998 Nov; 153(5):1573-8. PubMed ID: 9811349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.